ABOUT
PSYCH is the leading data and insights platform for the psychedelic healthcare industry.
PSYCH highlights key players, innovations and milestones, providing trustworthy insights for investors to cut through the noise and identify real opportunities.
We provide perspective on the impact of modernising regulations and improving access to psychedelic medicine, revealing the socioeconomic cost-benefits.
PSYCH Symposium: London is Europe's leading psychedelic medicine conference, providing a stage for the industry’s most influential figures to connect, collaborate, and expedite the adoption of psychedelic healthcare.
PREVIOUS EVENTS
July 6, 2023 | PSYCH Symposium: London 2023
Sponsored by: Cybin, Negev Capital, Clerkenwell Health & FTI Consulting
November 17, 2022 | Emerging Innovations In Psychedelic Healthcare
Sponsored by: Cybin, Awakn and Negev Capital
May 11, 2022 | PSYCH Symposium: London 2022
Sponsored by: MindMed, Filament Health and Biomind Labs
October 7, 2021 | PSYCH Investor Summit: Data & Technology
Sponsored by: MINDCURE, Novamind and aNUma
July 7, 2021 | PSYCH Investor Summit: Research & Development
Sponsored by: Gwella Mushrooms, Braxia Scientific and Tryp Therapeutics
April 18, 2021 | PSYCH Investor Summit: Europe & Asia
Sponsored by: Field Trip, Wake Network and MagicMed
